Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06868537 · ClinicalTrials.gov registry record · NA

A Trial of the Launching! to Adulthood Program

A NA study of Autism Spectrum Disorder (ASD), sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06868537: Recruiting NA study of Autism Spectrum Disorder (ASD), sponsored by The University of Texas Health Science Center, Houston.

NCT06868537 is a NA study of Autism Spectrum Disorder (ASD) that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants, below the 100-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06868537, a NA study of Autism Spectrum Disorder (ASD), is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine whether the Launching intervention leads to improvements in executive functioning, co-occurring mental health symptoms, and quality of life, as measured by caregiver and self-report assessments, to assess the maintenance of treatment gains 12 weeks post-treatment and to replicate the findings of the Launching pilot study in an independent sample of young adults with ASD.

Primary Outcome

This is a 239 item questionnaire and each is scored from 0(is not able to do this behavior) to 3 \[(always able to do this behavior)(or almost always)\] a higher number indicating better outcome

Interventions

  • BEHAVIORAL Launching! to adulthood group therapy
  • BEHAVIORAL standard of care

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-15
Est. Completion 2027-09-01
Phase NA

What NCT06868537 shows while recruiting

NCT06868537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 100-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Autism Spectrum Disorder (ASD) appearing as the primary indexed condition, and to 2 interventions - of which Launching! to adulthood group therapy is the first listed.

NCT06868537 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06868537 about?

NCT06868537 is a clinical study titled "A Trial of the Launching! to Adulthood Program". The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine w...

What is the current status of trial NCT06868537?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-15. Estimated completion is 2027-09-01.

What conditions does trial NCT06868537 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder (ASD).

What interventions are being tested in trial NCT06868537?

The interventions under investigation include: Launching! to adulthood group therapy (BEHAVIORAL), standard of care (BEHAVIORAL).

Who is sponsoring clinical trial NCT06868537?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06868537 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder (ASD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06868537's enrollment target sits among peer trials

40 10th of 16 higher than 7 of 16 other Autism Spectrum Disorder (ASD) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder (ASD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06868537, the US trial registry maintained by the National Library of Medicine. NCT06868537 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.